1. Home
  2. UONE vs PYPD Comparison

UONE vs PYPD Comparison

Compare UONE & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban One Inc.

UONE

Urban One Inc.

N/A

Current Price

$1.25

Market Cap

52.6M

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.00

Market Cap

57.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UONE
PYPD
Founded
1980
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.6M
57.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UONE
PYPD
Price
$1.25
$4.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
29.2K
87.0K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$393,670,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$2.30
52 Week High
$1.90
$4.07

Technical Indicators

Market Signals
Indicator
UONE
PYPD
Relative Strength Index (RSI) 54.36 66.27
Support Level $1.16 $3.94
Resistance Level $1.25 $4.07
Average True Range (ATR) 0.07 0.14
MACD 0.01 0.02
Stochastic Oscillator 55.26 91.23

Price Performance

Historical Comparison
UONE
PYPD

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: